Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Nitrome Biosciences
435 Henley Rd., PO Box 4971
Jackson, WY 83001
Phone: 650-689-0307

Nitrome Biosciences is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson's disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson's. While the initial focus is on Parkinson's disease, the company aims to expand its proprietary platform to include other disease indications. Nitrome has been widely recognized, and has won multiple awards including the prestigious Target Advancement grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).

Key Contact
Name
Dr. Irene Griswold-Prenner
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/24/20 $38,000,000 Series A AbbVie Biotech Ventures
Alexandria Venture Investments
Dementia Discovery Fund
Mission Holdings
Sofinnova Ventures
undisclosed